ABSTRACT
Background The psychosis spectrum is associated with structural dysconnectivity concentrated in transmodal association cortex. However, understanding of this pathophysiology has been limited by an exclusive focus on the direct connections to a region. Using Network Control Theory, we measured variation in both direct and indirect structural connections to a region to gain new insights into the pathophysiology of the psychosis spectrum.
Methods We used psychosis symptom data and structural connectivity in 1,068 youths aged 8 to 22 years from the Philadelphia Neurodevelopmental Cohort. Applying a Network Control Theory metric called average controllability, we estimated each brain region’s capacity to leverage its direct and indirect structural connections to control linear brain dynamics. Next, using non-linear regression, we determined the accuracy with which average controllability could predict negative and positive psychosis spectrum symptoms in out-of-sample testing. We also compared prediction performance for average controllability versus strength, which indexes only direct connections to a region. Finally, we assessed how the prediction performance for psychosis spectrum symptoms varied over the functional hierarchy spanning unimodal to transmodal cortex.
Results Average controllability outperformed strength at predicting positive psychosis spectrum symptoms, demonstrating that indexing indirect structural connections to a region improved prediction performance. Critically, improved prediction was concentrated in association cortex for average controllability, whereas prediction performance for strength was uniform across the cortex, suggesting that indexing indirect connections is crucial in association cortex.
Conclusions Examining inter-individual variation in direct and indirect structural connections to association cortex is crucial for accurate prediction of positive psychosis spectrum symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by grants from the National Institute of Mental Health: R21MH106799 (D.S.B. & T.D.S.), R01MH113550 (T.D.S. & D.S.B.), and RF1MH116920 (T.D.S. & D.S.B.). Additional support was provided by R01MH120482 (T.D.S.), R01MH107703 (T.D.S.), the John D. and Catherine T. MacArthur Foundation (D.S.B.), the Army Research Office contracts W911NF-14-1-0679 and W911NF-16-1-0474 (D.S.B.), the Army Research Laboratory contract W911NF-10-2-0022 (D.S.B.), R01MH107235 (R.C.G.), R01 MH119219 (R.C.G. and R.E.G.), R01 MH119185 (D.R.R.), R01 MH120174 (D.R.R.), R01MH113565 (D.H.W.) and the Penn-CHOP Lifespan Brain Institute. The PNC was supported by RC2MH089983 and RC2MH089924.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review boards of both the University of Pennsylvania and the Children's Hospital of Philadelphia approved all study procedures.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are from the open access The Philadelphia Neurodevelopmental Cohort (access number: phs000607.v3.p2)
